Cardiovascular

Latest News

Christian Ruff, MD
Dr Ruff Explores Mitigating Surgical Bleeding in AFib With Abelacimab

February 6th 2025

Favorable bleeding outcomes related to abelacimab have positioned the medication as a potential game changer in the treatment of atrial fibrillation.

Conceptualizing reduced cost and increased value | image credit: patpitchaya - stock.adobe.com
Polypill Treatment: A Clinically Effective and Cost-Saving Strategy for CVD Management

February 3rd 2025

FDA approval | image credit: Aquir - stock.adobe.com
FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD

January 28th 2025

Glass of sugar cubes | Image Credit: © grzejnik1981-stock.adobe.com
Curbing Sugary Beverages for Health and Economic Gains

January 28th 2025

Atrial fibrillation | image credit: Uladzlislau - stock.adobe.com
Abelacimab, a “Game Changer” for High-Risk Patients With AFib: Dr Ruff and Dr Bloomfield Elaborate on Latest Data From AZALEA-TIMI 71 Trial

January 22nd 2025

Advancements in Population Health Strategies for Cardiovascular Risk Management

Experts discuss how lipoproteins drive atherosclerotic heart disease, review the different guidelines and recommendations on Lp(a) testing, and insights from clinical trials.

Hands holding a heart with a heartbeat on it and the words AJMC Insights

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo